Tech News, Magazine & Review WordPress Theme 2017
  • Home
  • Supply Chain Updates
  • Global News
  • Contact Us
  • Home
  • Supply Chain Updates
  • Global News
  • Contact Us
No Result
View All Result
No Result
View All Result
Home Supply Chain Updates

How Coronavirus Is Affecting The U.S. Pharmaceutical Supply

usscmc by usscmc
March 12, 2020
How Coronavirus Is Affecting The U.S. Pharmaceutical Supply
Share on FacebookShare on Twitter

The coronavirus outbreak that originated in Wuhan, China, is causing businesses, health officials and patients to worry about potential shortages of prescription drugs.

That’s because the vast majority of active ingredients in medicines dispensed in the U.S. are made in factories overseas, many in China.

NPR has exclusive reporting on how disruptions in China are affecting some drugmakers’ ability to make key ingredients. On March 3, we emailed facilities registered with the U.S. Food and Drug Administration to ask what products they manufacture, how the outbreak was affecting their work and how they were coping.

Since then, nine companies with operations in China spoke directly to NPR. The facilities make a wide range of pharmaceuticals and some also make other health-related products, including nasal strips and agricultural insecticides.

So far, the serious supply disruptions many have feared haven’t come to pass. Many facilities are back online after production interruptions related to the coronavirus response. Others say they were far enough from the epicenter of the outbreak in Wuhan to continue working immediately after the extended Chinese New Year break.

Still, even facilities that are almost back to normal are anticipating a second wave of setbacks.

“A lot of our suppliers still are not answering phones because they can’t get to work or their site isn’t open,” says Elut Hsu, president of Morrisville, N.C.-based Asymchem, Inc., which has eight facilities in northeast China that manufacture drugs and drug ingredients. Asymchem is a contract manufacturer whose ingredients go into antibiotics, oncology drugs and antivirals sold by other companies.

Asymchem had replenished ingredients and supplies ahead of the new year holiday.

“We always stock up enough for at least a month,” she says. “So we’re OK for now. But the secondary wave of supply issues could be coming.”

Some projects had no interruptions, and others were delayed about four weeks, she says. That kind of delay usually isn’t enough to prompt a shortage.

Hsu says the extent of the outbreak became apparent to her colleagues in China as they were preparing to travel home for Chinese New Year at the end of January. Many employees are from other parts of the country. Some cut their holidays short to return to work on time, but others needed to remain in quarantine.

Although the Asymchem facilities in China were able to reopen on Feb. 10, the southernmost facility — nearest to Wuhan — was working with a smaller staff. It’s taken weeks to return to their normal workforce.

Many manufacturers are taking extra precautions to avoid the virus. Some people tell NPR they’re required to eat meals alone, wear masks to work, and have their temperatures checked once a day or more. They also avoid gatherings like meetings.

Gary Ye, of Tianyu Pharmaceuticals, says his facility couldn’t start back up until the last week in February because there were more than 100 coronavirus cases in his city, Taizhou, on Feb. 10. Although he says no one who works at Tianyu Pharmaceuticals has been diagnosed with the illness, they returned to work with extra requirements to keep the virus from spreading. His facility makes drug substances bound for the United States, including losartan for hypertension and montelukast for allergies and asthma.

“It had some impact to our business, we had to explain to clients we could not meet some deadlines in some cases,” he wrote in an email. “For drug substance manufacturing, it’s quite difficult to speed up, the only thing we can do is to make the most of our production capacity.”

He says his facility also experienced difficulties related to travel restrictions between provinces and cities. Although medical and living supplies were allowed through borders, manufacturing material was not. Those restrictions have since been lifted.

“It’s very costly for all kinds of measures China are taking, but obviously quite effective and successful,” he added.

Spread of coronavirus in China has slowed dramatically and businesses have begun to resume work..

“At this stage, most of the companies seem to be largely in operation,” says Benjamin England, a consultant and attorney with several dozen clients who import products to the U.S. Many manufacture drugs in China. “We’re not at least hearing of there being continued delay or restrictions with respect to production. And that’s true on the medical device side, too.”

Sheng Ding, dean of pharmacy at Tsinghua University in Beijing, says most drug manufacturing in China operates outside of Wuhan and is therefore returning to normal. “Things (e.g., getting back to work in full speed) are changing pretty quickly, especially in the last week as the outbreak situation is under control,” he wrote in an email.

Several U.S. drugmakers, including Pfizer and Mylan, have told their investors that the virus could harm their ability to manufacture products or get supplies to do so.

The Food and Drug Administration says it is in contact with more than 180 drug manufacturing facilities, and as of Feb. 26 it had identified 20 products or ingredients that are exclusively manufactured in China and could go into shortage.

The agency said on Feb. 27 that only one shortage has officially been attributed to the outbreak so far because manufacturers can’t get the active pharmaceutical ingredient they need to make it.

The agency didn’t name the drug and said there are alternatives for patients.

A 2012 law requires companies to tell the FDA if they are having manufacturing problems six months in advance of a possible shortage — or as soon as they know. Then, the FDA can jump in to help prevent a shortage.

But the law has its weaknesses, says Erin Fox, senior director of drug information and support services at the University of Utah Health Hospitals, who tracks national drug shortages. “If the company chooses not to report, nothing bad happens to them,” she says. “They don’t get fined.”

What’s more, companies aren’t legally required to tell the FDA why their drug is in shortage. And they can’t force a company to make a drug if it doesn’t want to anymore.

The agency gets “a lot of blame when drugs are short, but they don’t really have much control at all,” Fox says.

Still, any drug shortages caused by coronavirus manufacturing disruptions probably won’t appear immediately or all at once, Fox says.

“If [manufacturers] bought six months worth of raw material before Chinese New Year and they’re maybe not ready to make a batch until right now, they may not run out of that raw material until later this fall,” Fox says. “And then by then, maybe things will be OK.”

Rachna Shah, a professor in the supply chain and operations department at Carlson School of Management at the University of Minnesota says she, too, is reassured by the knowledge that drug manufacturers hold months of inventory.

“There’s more fear than there needs to be,” she says.

Copyright 2020 NPR. To see more, visit https://www.npr.org.
WABE brings you the local stories and national news that you value and trust. Please make a gift today.
usscmc

usscmc

No Result
View All Result

Recent Posts

  • How Hapag Lloyd captured a major market share in the Container Shipping Industry in USA
  • Why USA’s East Coast is the Favorite Destination for Manufacturing Companies
  • How Trade Relations Between the USA and UK Improved After Keir Starmer Became Prime Minister
  • Tips and Tricks for Procurement Managers to Handle Their Supplier Woes
  • The Crazy Supply Chain of Walmart Spanning Across the Globe

Recent Comments

  • Top 5 Supply Chain Certifications that are in high demand | Top 5 Certifications on Top 5 Globally Recognized Supply Chain Certifications
  • 3 Best Procurement Certifications that are most valuable | Procurement Newz on Top 5 Globally Recognized Supply Chain Certifications

Archives

  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • September 2019

Categories

  • Global News
  • Supply Chain Updates

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Antispam
  • Contact Us
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms of Use

© 2025 www.usscmc.com

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
No Result
View All Result
  • Home
  • Supply Chain Updates
  • Global News
  • Contact Us

© 2025 www.usscmc.com